927 related articles for article (PubMed ID: 26898970)
1. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
[TBL] [Abstract][Full Text] [Related]
2. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
[TBL] [Abstract][Full Text] [Related]
3. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
[TBL] [Abstract][Full Text] [Related]
4. [Remote monitoring and follow up of implantable cardioverter defibrillators and cardiac resynchronization therapy devices].
Guevara-Valdivia ME; Echegaray-Trelles A; Hernández J; Cordero-Pérez Lde J; Valderrama de-León R; Santos MA; Huarte-Hernández Y
Arch Cardiol Mex; 2011; 81(2):93-9. PubMed ID: 21775242
[TBL] [Abstract][Full Text] [Related]
5. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
[TBL] [Abstract][Full Text] [Related]
6. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
[TBL] [Abstract][Full Text] [Related]
7. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
[TBL] [Abstract][Full Text] [Related]
8. Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study.
Sardu C; Santamaria M; Rizzo MR; Barbieri M; di Marino M; Paolisso G; Santulli G; Marfella R
Int J Clin Pract; 2016 Jul; 70(7):569-76. PubMed ID: 27291327
[TBL] [Abstract][Full Text] [Related]
9. [The evaluation of the ventricular arrhythmias and interventions of cardiac implantable electronic devices in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death in ambulatory and telemetric follow-up].
Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
Pol Merkur Lekarski; 2017 Jan; 42(247):13-20. PubMed ID: 28134226
[TBL] [Abstract][Full Text] [Related]
10. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up.
Buchta P; Tajstra M; Kurek A; Skrzypek M; Świetlińska M; Gadula-Gacek E; Wasiak M; Pyka Ł; Gąsior M
Kardiol Pol; 2017; 75(6):573-580. PubMed ID: 28150288
[TBL] [Abstract][Full Text] [Related]
11. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
[TBL] [Abstract][Full Text] [Related]
12. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients.
Jędrzejczyk-Patej E; Lenarczyk R; Mazurek M; Liberska A; Przybylska-Siedlecka K; Podolecki T; Kowalczyk J; Sokal A; Leopold-Jadczyk A; Kowalski O; Kalarus Z
Europace; 2016 Mar; 18(3):436-44. PubMed ID: 26017467
[TBL] [Abstract][Full Text] [Related]
13. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(7):1-199. PubMed ID: 30443279
[TBL] [Abstract][Full Text] [Related]
14. [Ventricular arrhythmia and device intervention analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death in telemetric follow-up].
Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
Przegl Lek; 2016; 73(11):830-6. PubMed ID: 29693364
[TBL] [Abstract][Full Text] [Related]
15. Remote monitoring: Doomed to let down or an attractive promise?
Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
[TBL] [Abstract][Full Text] [Related]
16. Protocol-driven remote monitoring of cardiac resynchronization therapy as part of a heart failure disease management strategy.
Smeets CJP; Verbrugge FH; Vranken J; Van der Auwera J; Mullens W; Dupont M; Grieten L; De Cannière H; Lanssens D; Vandenberk T; Storms V; Thijs IM; Vandervoort P
Acta Cardiol; 2018 Jun; 73(3):230-239. PubMed ID: 28803515
[TBL] [Abstract][Full Text] [Related]
17. Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events.
Szepietowska B; Polonsky B; Sherazi S; Biton Y; Kutyifa V; McNitt S; Aktas M; Moss AJ; Zareba W
Cardiovasc Diabetol; 2016 Jul; 15():93. PubMed ID: 27388610
[TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
[TBL] [Abstract][Full Text] [Related]
19. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.
Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
Arch Cardiovasc Dis; 2016 Oct; 109(10):563-585. PubMed ID: 27595465
[TBL] [Abstract][Full Text] [Related]
20. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
